Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term open-label lacosamide in pediatric focal epilepsy (China)
CTR20160915Phase 2Completed
- Sponsor
- UCB
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lacosamide in epilepsy, sponsored by UCB. Started May 2018; status: completed.
02
Drugs
lacosamide
03
Conditions
epilepsy
Beyond the preview
Go deeper on CTR20160915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160915.